SynthesisFrontiers in pharmacology2023

Meta-analysis of efficacy and safety of bevacizumab in the treatment of hereditary hemorrhagic telangiectasia epistaxis.

Huimin Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.